FK-506-13C,D2 (Major) (Tacrolimus) (>85%)
Share product
- structure.search.product.name FK-506-13C,D2 (Major) (Tacrolimus) (>85%)
- 产品代码 TRC-F370002
- CAS登记号 1356841-89-8
- 品牌: TRC
Product Overview
产品代码
TRC-F370002
CAS登记号
产品形式
Neat
分子式
13C C43 D2 H67 N O12
分子量
807.02
API家族
Tacrolimus产品类型
TRC - Toronto Research Chemicals, Immunosuppressants, Immunosuppressants, Cytokine and Growth Factor Signalling Modulators, Stable isotopes, Immunosuppressants, Additional Neuro Products, Stable isotopes, Stable Isotope Labelled Analytical Standards, Neurology Research Chemicals and Analytical Standards, Cancer Research Chemicals and Analytical Standards, API Reference Standards & Research Materials
无标签CAS登记号
药物类型
Immunosuppressants
证明文件
要找其他批次?
{{ errors[0] }}
{{ errors[0] }}
如需了解有关我们数据处理活动的信息,请访问我们的《隐私声明》。
请输入您的电子邮件地址,我们将通过电子邮件向您发送批次的相关CoA:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}
{{ errors[0] }}
我们会将CoA发送到您的电子邮件地址 {{ coaEmailPopupData.userEmail }}
您的请求已发送给我们的销售团队处理。
产品信息
Chemical Data
分析物名称
Tacrolimus (13C,D2)
CAS登记号
1356841-89-8
分子式
13C C43 D2 H67 N O12
分子量
807.02
精确质量测定
806.4979
SMILES
[2H][13C](=CC[C@@H]1\C=C(/C)\C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCC[C@H](C3)C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)\C(=C\[C@@H]4CC[C@@H](O)[C@@H](C4)OC)\C)[2H]
InChI
InChI=1S/C44H69NO12/c1-10-12-31-18-25(2)17-26(3)19-37(54-8)40-38(55-9)21-28(5)44(52,57-40)41(49)42(50)45-16-11-13-32(24-45)43(51)56-39(29(6)34(47)23-35(31)48)27(4)20-30-14-15-33(46)36(22-30)53-7/h10,18,20,26,28-34,36-40,46-47,52H,1,11-17,19,21-24H2,2-9H3/b25-18+,27-20+/t26-,28+,29+,30-,31+,32+,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1/i1+1D2
无标签CAS登记号
104987-11-3
SIL类型
Carbon, Deuterium
产品数据
存储温度
-20°C
运输温度
Room Temperature
原产国
CANADA
产品类型
Stable Isotope Labelled; API
产品形式
Neat
API家族
Product Description
A labelled immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release. A representative lot contained a distribution of 20% d-1, 40% d-2 and 20% d-3.
References: Asano, K., et al.: In Vivo, 10, 537 (1996), McCall, E., et al.: Circ. Res., 79, 1110 (1996), Raufman, J.P., et al.: J. Biol. Chem., 271, 19877 (1996), Rokaw, M.D., et al.: Am. J. Physiol., 271, C194 (1996), Knoll, G.A., et al.: Brit. Med. J., 318, 1104 (1999),
{{ errors[0] }}